Found 230 results
Badal SS, Wang Y, Long J, Corcoran DL, Chang BH, Truong LD, Kanwar YS, Overbeek PA, Danesh FR.  2016.  miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy.. Nat Commun. 7:12076.
Lemley KV, Bagnasco SM, Nast CC, Barisoni L, Conway CM, Hewitt SM, Song PXK.  2016.  Morphometry Predicts Early GFR Change in Primary Proteinuric Glomerulopathies: A Longitudinal Cohort Study Using Generalized Estimating Equations.. PLoS One. 11(6):e0157148.
Li H-D, Menon R, Eksi R, Guerler A, Zhang Y, Omenn GS, Guan Y.  2016.  A Network of Splice Isoforms for the Mouse.. Sci Rep. 6:24507.
Valiño-Rivas L, Gonzalez-Lafuente L, Sanz AB, Ruiz-Ortega M, Ortiz A, Sanchez-Niño MD.  2016.  Non-canonical NFκB activation promotes chemokine expression in podocytes.. Sci Rep. 6:28857.
Sugar T, Wassenhove-McCarthy DJ, A Orr W, Green J, van Kuppevelt TH, McCarthy KJ.  2016.  N-sulfation of heparan sulfate is critical for syndecan-4-mediated podocyte cell-matrix interactions.. Am J Physiol Renal Physiol. 310(10):F1123-35.
Papadopoulos T, Krochmal M, Cisek K, Fernandes M, Husi H, Stevens R, Bascands J-L, Schanstra JP, Klein J.  2016.  Omics databases on kidney disease: where they can be found and how to benefit from them.. Clin Kidney J. 9(3):343-52.
Wickman L, Hodgin JB, Wang SQ, Afshinnia F, Kershaw D, Wiggins RC.  2016.  Podocyte Depletion in Thin GBM and Alport Syndrome.. PLoS One. 11(5):e0155255.
Wyatt CM, Schlondorff D.  2016.  Precision medicine comes of age in nephrology: identification of novel biomarkers and therapeutic targets for chronic kidney disease.. Kidney Int. 89(4):734-7.
Ding F, Tan A, Ju W, Li X, Li S, Ding J.  2016.  The Prediction of Key Cytoskeleton Components Involved in Glomerular Diseases Based on a Protein-Protein Interaction Network.. PLoS One. 11(5):e0156024.
Wagner MC, Campos-Bilderback SB, Chowdhury M, Flores B, Lai X, Myslinski J, Pandit S, Sandoval RM, Wean SE, Wei Y et al..  2016.  Proximal Tubules Have the Capacity to Regulate Uptake of Albumin.. J Am Soc Nephrol. 27(2):482-94.
Naik AS, Afshinnia F, Cibrik D, Hodgin JB, Wu F, Zhang M, Kikuchi M, Wickman L, Samaniego M, Bitzer M et al..  2016.  Quantitative podocyte parameters predict human native kidney and allograft half-lives.. JCI Insight. 1(7)
McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood AR, Teumer A, Kang HMin, Fuchsberger C, Danecek P, Sharp K et al..  2016.  A reference panel of 64,976 haplotypes for genotype imputation.. Nat Genet. 48(10):1279-83.
Mullins LJ, Conway BR, Menzies RI, Denby L, Mullins JJ.  2016.  Renal disease pathophysiology and treatment: contributions from the rat.. Dis Model Mech. 9(12):1419-1433.
Riccio P, Cebrian C, Zong H, Hippenmeyer S, Costantini F.  2016.  Ret and Etv4 Promote Directed Movements of Progenitor Cells during Renal Branching Morphogenesis.. PLoS Biol. 14(2):e1002382.
Jiang L, Hindmarch CCT, Rogers M, Campbell C, Waterfall C, Coghill J, Mathieson PW, Welsh GI.  2016.  RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways.. Sci Rep. 6:35671.
Yu H, Artomov M, Brähler S, M Stander C, Shamsan G, Sampson MG, J White M, Kretzler M, Miner JH, Jain S et al..  2016.  A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis.. J Clin Invest. 126(4):1603.
Yu H, Artomov M, Brähler S, M Stander C, Shamsan G, Sampson MG, J White M, Kretzler M, Miner JH, Jain S et al..  2016.  A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis.. J Clin Invest. 126(3):1067-78.
Yao Y, Inoki K.  2016.  The role of mechanistic target of rapamycin in maintenance of glomerular epithelial cells.. Curr Opin Nephrol Hypertens. 25(1):28-34.
Yao Y, Wang J, Yoshida S, Nada S, Okada M, Inoki K.  2016.  Role of Ragulator in the Regulation of Mechanistic Target of Rapamycin Signaling in Podocytes and Glomerular Function.. J Am Soc Nephrol. 27(12):3653-3665.
Saito R, Rocanin-Arjo A, You Y-H, Darshi M, Van Espen B, Miyamoto S, Pham J, Pu M, Romoli S, Natarajan L et al..  2016.  Systems biology analysis reveals role of MDM2 in diabetic nephropathy.. JCI Insight. 1(17):e87877.
Gillies CE, Otto EA, Vega-Warner V, Robertson CC, Sanna-Cherchi S, Gharavi A, Crawford B, Bhimma R, Winkler C, Kang HMin et al..  2016.  tarSVM: Improving the accuracy of variant calls derived from microfluidic PCR-based targeted next generation sequencing using a support vector machine.. BMC Bioinformatics. 17(1):233.
Sas KM, Kayampilly P, Byun J, Nair V, Hinder LM, Hur J, Zhang H, Lin C, Qi NR, Michailidis G et al..  2016.  Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications.. JCI Insight. 1(15):e86976.
Hur J, O'Brien PD, Nair V, Hinder LM, McGregor BA, Jagadish HV, Kretzler M, Brosius FC, Feldman EL.  2016.  Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns.. Diabetologia. 59(6):1297-306.
Betz B, Conway BR.  2016.  An Update on the Use of Animal Models in Diabetic Nephropathy Research.. Curr Diab Rep. 16(2):18.
Betz BB, Jenks SJ, Cronshaw AD, Lamont DJ, Cairns C, Manning JR, Goddard J, Webb DJ, Mullins JJ, Hughes J et al..  2016.  Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.. Kidney Int. 89(5):1125-1135.